Denosumab — Dosing in CKD & Dialysis

Denosumab (Monoclonal Antibody): renal dosing adjustments, dialyzability (Not measured: in a study of 55 patients with renal function from normal to dialysis-dependent, renal impairment had no effect on denosumab pharmacokinetics (Prolia label 12.3; Block 2012, PMID 22461041), and denosumab is a hum

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.